- Home
- FRSX vs IMRN Comparison
FRSX vs IMRN Comparison
Compare FRSX & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- IMRN
- Stock Information
- Founded
- FRSX N/A
- IMRN 1994
- Country
- FRSX Israel
- IMRN Australia
- Employees
- FRSX N/A
- IMRN N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- IMRN Health Care
- Exchange
- FRSX Nasdaq
- IMRN Nasdaq
- Market Cap
- FRSX 11.4M
- IMRN 9.2M
- IPO Year
- FRSX 2017
- IMRN N/A
- Fundamental
- Price
- FRSX $0.55
- IMRN $1.70
- Analyst Decision
- FRSX
- IMRN Strong Buy
- Analyst Count
- FRSX 0
- IMRN 1
- Target Price
- FRSX N/A
- IMRN $5.00
- AVG Volume (30 Days)
- FRSX 209.3K
- IMRN 53.0K
- Earning Date
- FRSX 06-17-2025
- IMRN 06-17-2025
- Dividend Yield
- FRSX N/A
- IMRN N/A
- EPS Growth
- FRSX N/A
- IMRN N/A
- EPS
- FRSX N/A
- IMRN N/A
- Revenue
- FRSX $436,000.00
- IMRN $4,048,286.00
- Revenue This Year
- FRSX N/A
- IMRN N/A
- Revenue Next Year
- FRSX N/A
- IMRN N/A
- P/E Ratio
- FRSX N/A
- IMRN N/A
- Revenue Growth
- FRSX N/A
- IMRN 82.90
- 52 Week Low
- FRSX $0.51
- IMRN $1.50
- 52 Week High
- FRSX $2.63
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- FRSX 39.88
- IMRN 43.37
- Support Level
- FRSX $0.53
- IMRN $1.69
- Resistance Level
- FRSX $0.66
- IMRN $1.89
- Average True Range (ATR)
- FRSX 0.03
- IMRN 0.17
- MACD
- FRSX -0.00
- IMRN -0.01
- Stochastic Oscillator
- FRSX 30.92
- IMRN 34.06
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.